Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Aroa Biosurgery

US

Last updated May 24, 2026

Part of Aroa Biosurgery Ltd.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (146)

Page 1 of 3
DeviceModel / ReferenceRegistriesClassStatus
Myriad Morcells™ PW02NA0100
FDA UDI
UActive
Symphony™ Proliferative Bioscaffold CM03HA100S
FDA UDI
UUnknown
Endoform Surface SR05LG1020
FDA UDI
UUnknown
Endoform™ Natural Restorative Bioscaffold 529313
FDA UDI
UActive
Endoform™ Antimicrobial Restorative Bioscaffold 629304
FDA UDI
UActive
Endoform Natural Dermal Template 529302
FDA UDI
UActive
Endoform Myriad MR03LG1020
FDA UDI
UUnknown
Restella R20153-0416G
FDA UDI
Class IIUnknown
Endoform™ Antimicrobial Restorative Bioscaffold 629311
FDA UDI
UActive
Myriad Morcells™ PW02NA0500
FDA UDI
UActive
Myriad Morcells™ PW01NA0500
FDA UDI
UActive
Endoform Natural Dermal Template 529315
FDA UDI
UActive
Ovitex® PRS R30353-1622G
FDA UDI
Class IIUnknown
Symphony™ Proliferative Bioscaffold CM03HA004S
FDA UDI
UActive
Restella R20143-2020P
FDA UDI
Class IIUnknown
Endoform Antimicrobial Dermal Template 629302
FDA UDI
UActive
Myriad Matrix™ Soft Tissue Bioscaffold SR02LG0710US
FDA UDI
UActive
Restella R20243-1122P
FDA UDI
Class IIUnknown
Myriad Morcells™ PW01NA1000
FDA UDI
UActive
Endoform Antimicrobial Dermal Template 629312
FDA UDI
UActive
Ovitex® PRS R30343-2022P
FDA UDI
Class IIUnknown
Endoform™ Natural Restorative Bioscaffold 529304
FDA UDI
UActive
Restella R20153-2020G
FDA UDI
Class IIUnknown
Ovitex® PRS R20153-1620G
FDA UDI
Class IIUnknown
Ovitex® PRS R20143-0820P
FDA UDI
Class IIUnknown
Restella R30343-1622P
FDA UDI
Class IIUnknown
Symphony™ Proliferative Bioscaffold CM03HA048R
FDA UDI
UUnknown
Ovitex® PRS R20353-2022G
FDA UDI
Class IIUnknown
Restella R20253-0815G
FDA UDI
Class IIUnknown
Symphony™ Proliferative Bioscaffold CM03HA002D
FDA UDI
UActive
Myriad Morcells™ PW02NA1000
FDA UDI
UActive
Restella R20243-1018P
FDA UDI
Class IIUnknown
Symphony™ Proliferative Bioscaffold CM03HA008R
FDA UDI
UUnknown
Ovitex® PRS R20343-2025P
FDA UDI
Class IIUnknown
Symphony™ Proliferative Bioscaffold CM03HA025S
FDA UDI
UActive
Endoform™ Antimicrobial Restorative Bioscaffold 629314
FDA UDI
UActive
Symphony™ Proliferative Bioscaffold CM03HA050R
FDA UDI
UActive
Restella R30353-2022G
FDA UDI
Class IIUnknown
Endoform Myriad MR03LG0505
FDA UDI
Class IIUnknown
Symphony™ Proliferative Bioscaffold CM03HA016S
FDA UDI
UActive
Endoform™ Antimicrobial Restorative Bioscaffold 629312
FDA UDI
UActive
Myriad Morcells™ PW02NA2000
FDA UDI
UUnknown
Endoform™ Antimicrobial Restorative Bioscaffold 629302
FDA UDI
UActive
Ovitex® PRS R20253-1018G
FDA UDI
Class IIUnknown
Endoform Myriad MR05LG1020
FDA UDI
UUnknown
Myriad Matrix™ Soft Tissue Bioscaffold SR02LG1010US
FDA UDI
UActive
Myriad Morcells™ PW02NA0200
FDA UDI
UActive
Myriad Ultra™ Reinforced BioScaffold – Permanent (PP) LP04PP1520
FDA UDI
Class IIUnknown
Ovitex® PRS R20243-0717P
FDA UDI
Class IIUnknown
Ovitex® PRS R20243-0815P
FDA UDI
Class IIUnknown

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (21)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Apr 6, 2018Z-0417-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0429-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0419-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0422-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0420-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0433-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0415-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0431-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0423-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0421-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0425-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0428-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0432-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0426-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0416-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0434-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0418-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0427-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0435-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0424-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0430-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.